Back
Xeris Biopharma Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Buy
74
XERS
Xeris Biopharma Holdings
Last Price:
$3.49
Seasonality Move:
-18.08%
Sell
19
NBY
NovaBay Pharmaceuticals
Last Price:
$0.53
Seasonality Move:
-0.66%
Buy
74
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
-
The current Xeris Biopharma Holdings [XERS] share price is $3.49. The Score for XERS is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
-
XERS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
-
The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
-
NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.49Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XERS is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.53The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
XERS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 55.91 | Buy |
Chaikin Money Flow: | 422045 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.09 - 3.55) | Buy |
Bollinger Bands (100): | (2.64 - 3.32) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 514099 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.53 - 0.67) | Sell |
Bollinger Bands (100): | (0.49 - 0.69) | Sell |
XERS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.39 | Buy |
20-day SMA: | 3.41 | Buy |
50-day SMA: | 3.24 | Buy |
200-day SMA: | 2.55 | Buy |
8-day EMA: | 3.41 | Buy |
20-day EMA: | 3.38 | Buy |
50-day EMA: | 3.24 | Buy |
200-day EMA: | 2.75 | Buy |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.54 | Sell |
20-day SMA: | 0.57 | Sell |
50-day SMA: | 0.63 | Sell |
200-day SMA: | 1.88 | Sell |
8-day EMA: | 0.54 | Sell |
20-day EMA: | 0.57 | Sell |
50-day EMA: | 0.64 | Sell |
200-day EMA: | 4.7 | Sell |
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.05 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Xeris Biopharma Holdings Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |